Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

Bibliographic Details
Main Authors: Mayer, Jiří, Arthur, Christopher, Delaunay, Jacques, Mazur, Grzegorz, Thomas, Xavier G, Wierzbowska, Agnieszka, Ravandi, Farhad, Berrak, Erhan, Jones, Mark, Li, Yuhan, Kantarjian, Hagop M
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928608/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928608/

Similar Items